Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 24: 1553-1556, 1978;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogden, J. D.
Right arrow Articles by Troiano, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogden, J. D.
Right arrow Articles by Troiano, R. A.

Clinical Chemistry, Vol 24, 1553-1556, Copyright © 1978 by American Association for Clinical Chemistry

Plasma calcium, copper, magnesium, and zinc concentrations in patients with the alcohol withdrawal syndrome

JD Bogden and RA Troiano

We determined zinc, copper, magnesium, and calcium concentrations by atomic absorption spectrophotometry in the plasma of 30 patients hospitalized for treatment of seizures during a period of alcohol withdrawal. Those patients who developed delirium tremens or a prolonged hallucinatory state had significantly higher plasma copper concentrations (P = 0.026), significantly lower zinc concentrations (P = 0.004), and significantly higher copper/zinc ratios (P = 0.001) than the patients who recovered uneventfully. Zinc deficiency may be one of the factors that contribute to the neurologic complications of alcoholism. A determination of the plasma copper/zinc ratio early in the course of alcohol withdrawal could be of value in indicating which patients have the most substantial underlying disease or metabolic imbalance and therefore may be at greatest risk of developing delirium tremens or prolonged hallucinosis.


The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Clin. Nutr.Home page
J. D Bogden, F. W Kemp, S. Han, W. Li, K. Bruening, T. Denny, J. M Oleske, J. Lloyd, H. Baker, G. Perez, et al.
Status of selected nutrients and progression of human immunodeficiency virus type 1 infection
Am. J. Clinical Nutrition, September 1, 2000; 72(3): 809 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
K. Ghose and A. Taylor
Hypercupraemia Induced by Antiepileptic Drugs
Human and Experimental Toxicology, January 1, 1983; 2(3): 519 - 529.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Association for Clinical Chemistry.